Page 3 - Cue Reader News Today

Cue Health (NASDAQ:HLTH – Get Rating) and Talis Biomedical (NASDAQ:TLIS – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership. Valuation and Earnings This table compares Cue Health and […]

09.05.2023 - Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced that it has made a De Novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue RSV Molecular Test for at-home and point-of-care ... Seite 1

Cue Health announced today that it made a de novo submission to the FDA for clearance of its RSV molecular test.

In a letter to employees, CEO Ayub Khattak said the diagnostics company's new initiatives are "progressing well but are still early in terms of revenue generation."

The de novo submission is for a molecular diagnostic test for respiratory syncytial virus meant for home and point-of-care use.

Cue Health Inc. (NASDAQ:HLTH – Get Rating) was the recipient of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 2,770,000 shares, a decrease of 7.0% from the March 31st total of 2,980,000 shares. Based on an average daily trading volume, of 261,400 shares, […]

10x Genomics (NASDAQ:TXG – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings. Analyst Ratings This is a breakdown of recent recommendations and […]

Cue Health Inc. (NASDAQ:HLTH – Get Rating) saw a significant decrease in short interest in March. As of March 15th, there was short interest totalling 2,750,000 shares, a decrease of 8.0% from the February 28th total of 2,990,000 shares. Approximately 3.2% of the shares of the stock are short sold. Based on an average daily […]

Should You Buy or Sell Cue Health Stock? Get The Latest HLTH Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Authorized for use in professional point-of-care settings, the nucleic acid amplification diagnostic tool delivers results in 25 minutes.